Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)

A. Ali (Telford, United Kingdom), J. Ibrahim (Telford, United Kingdom), T. Khan (Telford, United Kingdom), J. Ahmed (Telford, United Kingdom), A. Sesan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), A. Makan (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom)

Source: International Congress 2019 – Airway diseases and blood cells
Session: Airway diseases and blood cells
Session type: Thematic Poster
Number: 2576
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ali (Telford, United Kingdom), J. Ibrahim (Telford, United Kingdom), T. Khan (Telford, United Kingdom), J. Ahmed (Telford, United Kingdom), A. Sesan (Telford, United Kingdom), E. Crawford (Telford, United Kingdom), K. Srinivasan (Telford, United Kingdom), H. Moudgil (Telford, United Kingdom), A. Makan (Telford, United Kingdom), N. Ahmad (Telford, United Kingdom). Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD). 2576

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Late Breaking Abstract - High blood neutrophils are associated with increased exacerbations and mortality in Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019

Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020

Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Novelties in pulmonary rehabilitation and chronic respiratory care
Year: 2020




Association between estimated Glomerular Filtration Rate (eGFR) and cardiovascular risk in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases
Year: 2017

Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002

Adaptive capacities and complexity of heart rate variability in patients with Chronic Obstructive Pulmonary Disease throughout pulmonary rehabilitation
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Rate of FVC decline in a primary care UK Chronic Obstructive Pulmonary Disease (COPD) population
Source: International Congress 2019 – Powerful cohort studies with/without lung function
Year: 2019



Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018


Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017